Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis.

Endocrinol Diabetes Metab · 2025 · PMC12163345 · PMID 40509955

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

For this reason, it is necessary to combine these results and identify an overall trend so that such data are not lost, and further larger‐scale trials are encouraged, which can then provide enough evidence to guide therapies. 7 Conclusion In conclusion, GLP‐1RA use in T2DM patients may be beneficial in lowering the risk of glaucoma in some circumstances.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.